Stocktoria

Vistagen Therapeutics, Inc. VTGN

Nasdaq · stock · Pharmaceutical Preparations · website · IPO 2010-10-18

Vistagen Therapeutics, Inc. statistics & valuation

Market cap$28.3M
P / S22.3×
P / B0.8×
Net margin-5491.3%
Return on equity-196.2%
Return on capital-201.6%

Market cap as of 2026-06-29. Multiples are price-derived and refreshed daily; everything else from the latest financial reports.

Profitability & efficiency

Net margin (%)
-820.40% -1646.10% -4306.80% -2759.60% -10579.80% -5491.30% 2017201820192020202120222023202420252026
Gross margin (%)
2017201820192020202120222023202420252026
Operating margin (%)
-819.90% -1646.10% -4308.30% -3103.50% -11517.10% -5683.70% 2017201820192020202120222023202420252026
Return on equity (%)
-1665.40% -207.40% -347.50% -19.50% -73.80% -490.50% -25.70% -73.00% -196.20% 2017201820192020202120222023202420252026
Shares outstanding
86.1M 6.6M 7.0M 19.4M 30.9M 38.1M 2017201820192020202120222023202420252026
Net debt ($)
2017201820192020202120222023202420252026
Share buybacks ($)
2017201820192020202120222023202420252026
Return on assets (%)
-276.30% -127.20% -175.50% -359.90% -16.60% -64.00% -280.90% -23.70% -61.00% -143.50% 2017201820192020202120222023202420252026
Free cash flow margin (%)
-600.10% -1133.40% -4098.90% 2017201820192020202120222023202420252026
Debt / equity (×)
2017201820192020202120222023202420252026
EPS ($)
-$8.51 -$1.52 -$1.67 -$1.83 2017201820192020202120222023202420252026

Margins and returns computed from annual filings. Falling shares outstanding = buybacks; rising = dilution. Net debt = debt − cash (negative = net cash).

Key ratios (by fiscal year)

RatioFY2026FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017
Operating margin-5683.7%-11517.1%-3103.5%26109.3%-4308.3%-1646.1%———-819.9%
Net margin-5491.3%-10579.8%-2759.6%26100.4%-4306.8%-1646.1%———-820.4%
FCF margin————-4098.9%-1133.4%———-600.1%
Return on assets-143.5%-61.0%-23.7%-280.9%-64.0%-16.6%-359.9%-175.5%-127.2%-276.3%
Return on equity-196.2%-73.0%-25.7%-490.5%-73.8%-19.5%362.6%-347.5%-207.4%-1665.4%
Current ratio3.676.5123.553.8312.3224.850.064.877.562.47

Computed from company filings · US · as of 2026-03-31. Facts plus Stocktoria's own computed scores — not investment advice.